367 related articles for article (PubMed ID: 25462211)
1. Is resveratrol a potential substitute for leuprolide acetate in experimental endometriosis?
Bayoglu Tekin Y; Guven S; Kirbas A; Kalkan Y; Tumkaya L; Guvendag Guven ES
Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():1-6. PubMed ID: 25462211
[TBL] [Abstract][Full Text] [Related]
2. A potential novel treatment strategy: inhibition of angiogenesis and inflammation by resveratrol for regression of endometriosis in an experimental rat model.
Ozcan Cenksoy P; Oktem M; Erdem O; Karakaya C; Cenksoy C; Erdem A; Guner H; Karabacak O
Gynecol Endocrinol; 2015 Mar; 31(3):219-24. PubMed ID: 25373440
[TBL] [Abstract][Full Text] [Related]
3. Is montelukast effective in regression of endometrial implants in an experimentally induced endometriosis model in rats?
Kiykac Altinbas S; Tapisiz OL; Cavkaytar S; Simsek G; Oguztuzun S; Goktolga U
Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():7-12. PubMed ID: 25462212
[TBL] [Abstract][Full Text] [Related]
4. Regression of endometrial implants by resveratrol in an experimentally induced endometriosis model in rats.
Ergenoğlu AM; Yeniel AÖ; Erbaş O; Aktuğ H; Yildirim N; Ulukuş M; Taskiran D
Reprod Sci; 2013 Oct; 20(10):1230-6. PubMed ID: 23536571
[TBL] [Abstract][Full Text] [Related]
5. The effect of captopril on endometriotic implants in a rat model.
Oktem M; Ozcan P; Erdem O; Karakaya C; Cenksoy C; Guner H; Karabacak O; Dursun P
Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():120-5. PubMed ID: 25090631
[TBL] [Abstract][Full Text] [Related]
6. Doxycycline causes regression of endometriotic implants: a rat model.
Akkaya P; Onalan G; Haberal N; Bayraktar N; Mülayim B; Zeyneloglu HB
Hum Reprod; 2009 Aug; 24(8):1900-8. PubMed ID: 19401321
[TBL] [Abstract][Full Text] [Related]
7. Theranekron for treatment of endometriosis in a rat model compared with medroxyprogesterone acetate and leuprolide acetate.
Dolapcioglu K; Dogruer G; Ozsoy S; Ergun Y; Ciftci S; Soylu Karapinar O; Aslan E
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):206-10. PubMed ID: 23827690
[TBL] [Abstract][Full Text] [Related]
8. Natural therapies assessment for the treatment of endometriosis.
Ricci AG; Olivares CN; Bilotas MA; Bastón JI; Singla JJ; Meresman GF; Barañao RI
Hum Reprod; 2013 Jan; 28(1):178-88. PubMed ID: 23081870
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis.
Rudzitis-Auth J; Menger MD; Laschke MW
Hum Reprod; 2013 May; 28(5):1339-47. PubMed ID: 23427233
[TBL] [Abstract][Full Text] [Related]
10. Viburnum opulus L.: A remedy for the treatment of endometriosis demonstrated by rat model of surgically-induced endometriosis.
Saltan G; Süntar I; Ozbilgin S; Ilhan M; Demirel MA; Oz BE; Keleş H; Akkol EK
J Ethnopharmacol; 2016 Dec; 193():450-455. PubMed ID: 27647013
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol as a potential novel treatment for endometriosis by its anti-inflammatory, antioxidative and antiangiogenic effects in an experimental rat model.
Okten SB; Cetin C; Tok OE; Guler EM; Taha SH; Ozcan P; Ficicioglu C
Reprod Biomed Online; 2023 May; 46(5):865-875. PubMed ID: 36997400
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol successfully treats experimental endometriosis through modulation of oxidative stress and lipid peroxidation.
Yavuz S; Aydin NE; Celik O; Yilmaz E; Ozerol E; Tanbek K
J Cancer Res Ther; 2014; 10(2):324-9. PubMed ID: 25022386
[TBL] [Abstract][Full Text] [Related]
13. Effect of oxytocin treatment on explant size, plasma and peritoneal levels of MCP-1, VEGF, TNF-α and histopathological parameters in a rat endometriosis model.
Yeniel AÖ; Erbas O; Ergenoglu AM; Aktug H; Taskiran D; Yildirim N; Ulukus M
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():134-9. PubMed ID: 24447470
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of colchicine in an experimental rat endometriosis model: histopathological evaluation and assessment of TNF-α levels.
Kurt RK; Pinar N; Karateke A; Okyay AG; Silfeler DB; Albayrak A; Özdemir S; Hakverdi AU
Reprod Sci; 2015 Feb; 22(2):258-63. PubMed ID: 25049286
[TBL] [Abstract][Full Text] [Related]
15. Effect of the bone marrow derived-mononuclear stem cells transplantation in the growth, VEGF-R and TNF-alpha expression of endometrial implants in Wistar rats.
Kondo W; Dal Lago EA; Francisco JC; Simeoni RB; de Noronha L; Martins AP; de Azevedo ML; Ferreira CC; Maestrelli P; Olandoski M; Guarita-Souza LC; do Amaral VF
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):298-304. PubMed ID: 21640466
[TBL] [Abstract][Full Text] [Related]
16. High-dose atorvastatin causes regression of endometriotic implants: a rat model.
Oktem M; Esinler I; Eroglu D; Haberal N; Bayraktar N; Zeyneloglu HB
Hum Reprod; 2007 May; 22(5):1474-80. PubMed ID: 17234677
[TBL] [Abstract][Full Text] [Related]
17. Regression of experimental endometriotic implants in a rat model with the angiotensin II receptor blocker losartan.
Cakmak B; Cavusoglu T; Ates U; Meral A; Nacar MC; Erbaş O
J Obstet Gynaecol Res; 2015 Apr; 41(4):601-7. PubMed ID: 25302540
[TBL] [Abstract][Full Text] [Related]
18. A mixture of St. John's wort and sea buckthorn oils regresses endometriotic implants and affects the levels of inflammatory mediators in peritoneal fluid of the rat: A surgically induced endometriosis model.
İlhan M; Süntar İ; Demirel MA; Yeşilada E; Keleş H; Küpeli Akkol E
Taiwan J Obstet Gynecol; 2016 Dec; 55(6):786-790. PubMed ID: 28040120
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol suppresses inflammatory responses in endometrial stromal cells derived from endometriosis: a possible role of the sirtuin 1 pathway.
Taguchi A; Wada-Hiraike O; Kawana K; Koga K; Yamashita A; Shirane A; Urata Y; Kozuma S; Osuga Y; Fujii T
J Obstet Gynaecol Res; 2014 Mar; 40(3):770-8. PubMed ID: 24320086
[TBL] [Abstract][Full Text] [Related]
20. Effects of Pazopanib, Sunitinib, and Sorafenib, Anti-VEGF Agents, on the Growth of Experimental Endometriosis in Rats.
Yildiz C; Kacan T; Akkar OB; Karakus S; Kacan SB; Ozer H; Cetin A
Reprod Sci; 2015 Nov; 22(11):1445-51. PubMed ID: 25963915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
